Tuberculin skin testing: Spectrum of adverse reactions.
Tuberculin skin testing (TST) is one of the primary diagnostic modalities recommended by the World Health Organization (WHO) and the National Institute for Health and Care Excellence (NICE) study conducted in the United Kingdom (UK) for diagnosing tuberculosis (TB). Even after acceptance as a diagnostic modality and stern standardization, TST has its own flaws that include a spectrum of adverse reactions. We report a series of cases with a spectrum of adverse reactions occurring with a higher frequency than present in the available evidence. The study has some demerits such as being a retrospective one with interobserver variation and lack of histopathological confirmation. The observation is presented to accentuate the fact that adverse reactions are not a rarity and that further studies are required to establish the cause and exact incidence of the same.
Graded Specialist, Department of Pediatrics, 92 Base Hospital, Srinagar, Jammu and Kashmir, India.
Ramar
R
Praveen
Amit
A
Bahuguna
Bhumesh Singh
BS
Dhadwal